Coronavirus fears have triggered volatility, a correction and ultimately a bear market in U.S. stocks in 2020. Many companies have suffered massive price drops, but a handful of stock picks have seen their prices hold up – and in some cases even soar. One such cluster includes pharmaceutical companies and other health-care stocks that are in the race to develop COVID-19 coronavirus vaccines and therapeutics.

Continue reading on Kiplinger.